uric acid has been researched along with benzbromarone in 208 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 70 (33.65) | 18.7374 |
1990's | 38 (18.27) | 18.2507 |
2000's | 24 (11.54) | 29.6817 |
2010's | 52 (25.00) | 24.3611 |
2020's | 24 (11.54) | 2.80 |
Authors | Studies |
---|---|
Endou, H; Hosoya, T; Hosoyamada, M; Ichida, K; Kimura, H; Takeda, M; Utsunomiya, Y | 1 |
Ashizawa, N; Iwanaga, T; Kobashi, S; Matsumoto, K; Miyata, S; Uda, J | 1 |
Mertz, DP | 5 |
Didier, M; Olmer, M | 1 |
Fanelli, GM | 1 |
Berg, G; Matzkies, F; Minzlaff, R | 1 |
Flury, W; Montandon, A; Ruch, HR | 1 |
Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
Arntz, HR; Dreykluft, HR; Leonhardt, H | 1 |
König, HJ | 1 |
Bresnik, W; Kuzmits, R; Müller, MM | 1 |
Barsom, S | 1 |
Giudicelli, C; Masbernard, A; Meunier, J; Ricordel, I; Schermann, JM | 1 |
Kleinschmidt, A; Schräpler, P; Schulz, E | 1 |
Haese, E; Kleinschmidt, A; Schräpler, P | 1 |
Matzkies, F | 4 |
Flügel, M; Geldmacher, J | 1 |
Akaoka, I; Masuda, T; Nishida, Y; Nishizawa, T | 1 |
Bröll, H; Eberl, R; Sochor, H; Tausch, G | 1 |
Enzensberger, W; Greiling, H; Stuhlsatz, HW | 1 |
Fox, IH; Sinclair, DS | 2 |
Bec, Ph; Pujo, JM; Suc, JM | 1 |
Berg, G; Matzkies, F | 2 |
Janzen, D; Kühnhold, O; Mertz, DP; Scheiffele, E | 1 |
Berg, G; Matzkies, F; Neuwirth, R | 1 |
Yu, TF | 1 |
Schräpler, P; Schulz, E | 1 |
Siegenthaler-Zuber, G | 1 |
Inagaki, H; Nakai, T; Shinosaki, T; Yamashita, T; Yonetani, Y | 1 |
Agbedana, EO; Higashino, K; Moriwaki, Y; Suda, M; Takahashi, S; Yamamoto, T | 1 |
Akaoka, I; Fujimori, S; Kaneko, K | 1 |
Empl, H; Gresser, U; Kamilli, I; Zöllner, N | 1 |
Agbedana, OE; Hada, T; Higashino, K; Moriwaki, Y; Suda, M; Takahashi, S; Yamamoto, T | 1 |
Tykarski, A | 1 |
Gresser, U | 1 |
Berg, H | 1 |
Binswanger, U; Hess, B | 1 |
Akiyama, T; Ikegami, M; Imanishi, M; Ishii, T; Kanda, H; Kunikata, S; Kurita, T; Matsuura, T; Nishioka, T; Uemura, T | 1 |
Malý, J; Schück, O | 1 |
Hada, T; Higashino, K; Moriwaki, Y; Takahashi, S; Yamamoto, T | 2 |
Goto, H; Ito, A; Mikami, T | 1 |
Hasegawa, J; Hisatome, I; Ishiko, R; Kotake, H; Mashiba, H; Nakamoto, S; Ogino, K; Saito, M | 1 |
Cabo, J; Gomez-Ruiz, MD; Izquierdo, R; Rodilla, F; Sanchez-Beltran, MJ | 1 |
de Vries, JX; Ittensohn, A; Kohlmeier, M; Walter-Sack, I; Weber, E | 1 |
Hasegawa, J; Hisatome, I; Kotake, H; Mashiba, H; Miyamoto, J; Nakamoto, S; Ogino, K; Saito, M | 1 |
Hesse, A; Schneeberger, W; Vahlensieck, W | 1 |
Schoeman, HS; Sommers, DK | 1 |
Malý, J | 1 |
Clavel, JP; Colin, JN; Dietlin, F; Farinotti, R; Fredj, G; Tod, M; Vignon, E | 1 |
Hwang, TJ; Ito, M; Kuroda, Y; Miyao, M; Naito, E; Takeda, E; Toshima, K; Watanabe, T; Yokota, I | 1 |
Eichhorn, R; Mertz, DP | 1 |
Gröbner, W; Löffler, W; Zöllner, N | 1 |
Homma, Y; Kitamura, T; Nishimura, Y | 1 |
Rodnan, GP | 1 |
Diehm, C; Mörl, H; Schöffel, G; Walter, E; Zimmermann, R | 1 |
Chandelier, C; Dupuich, Y; Niquet, G | 1 |
Brzozowska-Jurkowska, AM; Kawenoki-Minc, E | 1 |
Brzozowska-Jurkowska, AM | 1 |
Bluestone, R; Klinenberg, J; Lee, IK | 1 |
Bader, U; Ferber, H; Matzkies, F | 1 |
Scott, WA | 1 |
Schepers, GW | 1 |
Dorn, M | 1 |
Kuroda, M; Takeda, R; Tofuku, Y | 1 |
Sailer, D | 1 |
Giudicelli, CP; Masbernard, A | 1 |
Levinson, DJ; Sorensen, LB | 3 |
Angar, T; Bach, GL; Grosse-Kielisch, C; Jelke, K; Jüttner, A; Krause, G; Neubauer, M | 1 |
Asch, G; Asch, L | 1 |
Danĕková, H; Dzúrik, R; Fedelesová, V; Hlavatá, E | 1 |
Asch, L; Schirardin, H; Weryha, A | 1 |
Bach, D; Hesse, A; Strenge, A; Vahlensieck, W | 1 |
Gathof, BS; Gresser, U; Gross, M | 1 |
Hiroshige, K; Kuroiwa, A; Takasugi, M; Yuu, K | 1 |
Kawai, S; Osawa, G; Yamada, M | 1 |
Bock, HA; Thiel, G; Zürcher, RM | 1 |
Balkarov, IM | 1 |
Posadzy-Małaczyńska, A; Pupek-Musialik, D; Tykarski, A | 1 |
Fujimoto, Y; Hirata, N; Hisatome, I; Kosaka, H; Kotake, H; Mashiba, H; Sato, R; Shigemasa, C; Tanaka, Y; Yoshida, A | 1 |
de Vries, JX; Empl, H; Gresser, U; Ittensohn, A; Walter-Sack, I; Weber, E; Zöllner, N | 1 |
Hiroshige, K; Kuroiwa, A; Soejima, M; Takasugi, M; Yuu, K | 1 |
Groenewoud, G; Hundt, HK; Müller, FO; Schall, R; van der Merwe, JC; van Dyk, M | 1 |
Fujimoto, Y; Hisatome, I; Igawa, O; Kosaka, H; Manabe, I; Ohtahara, A; Ohtahara, K; Sawaguchi, M; Shigemasa, C; Takeda, A; Tanaka, Y; Tsuboi, M; Yoshida, A | 1 |
Higashino, K; Hiroishi, K; Moriwaki, Y; Naito, Y; Nasako, Y; Takahashi, S; Yamakita, J; Yamamoto, T | 1 |
Diezi, J; Guisan, B; Roch-Ramel, F | 1 |
Fujita, K; Hirasaki, S; Koide, N; Ogawa, H; Tsuji, T | 1 |
Goriki, K; Ochiai, M; Okusaki, K; Takahashi, H; Toda, K; Tokunou, H; Uehara, S | 1 |
de Vries, JX; Pfleilschifter, V; Raedsch, R; von Bubnoff, A; Walter-Sack, I | 1 |
Hirai, A; Saito, Y | 1 |
Higashino, K; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamakita, J; Yamamoto, T | 2 |
Hamada, N; Hiroe, K; Hisatome, I; Kato, T; Kinugawa, T; Manabe, I; Ogino, K; Ohtahara, A; Sato, R; Shigemasa, C; Shimoyama, M; Takeda, A; Tanaka, Y; Tsuboi, M; Yamamoto, Y; Yoshida, A | 1 |
Grahame, R; Marsh, FP; McBride, MB; Simmonds, HA | 1 |
Fend, F; Gruber, J; König, P; Lhotta, K; Sgonc, R | 1 |
Decaux, G; Hannotier, P; Musch, W; Prospert, F; Soupart, A | 1 |
Alonso-Ruiz, A; Calabozo, M; García-Erauskin, G; Herrero-Beites, A; Perez-Ruiz, F; Ruiz-Lucea, E | 1 |
Chazerain, P; Ziza, JM | 1 |
Furuyama, T; Ikarashi, T; Ito, S; Kurihara, I; Miura, R; Saito, T; Sato, H; Sato, M; Soma, J; Suzuki, T; Tsunoda, K | 1 |
Ito, A; Mikami, T; Yoshino, Y | 1 |
Calabozo, M; García-Erauskin, G; Herrero-Beites, AM; Perez-Ruiz, F; Pijoan, JI | 1 |
Gröbner, W; Walter-Sack, I | 1 |
Arai, M; Fujiwara, K; Hirasawa, H; Kanda, T; Kojima, H; Saisho, H; Yokosuka, O | 1 |
Akkasilpa, S; Deesomchok, U; Hanvivadhanakul, P | 1 |
Calabozo, M; Herrero-Beites, AM; Perez-Ruiz, F; Pijoan, JI; Ruibal, A | 1 |
Hasegawa, Y; Ito, O; Ito, S; Kudo, K; Mitsui, H; Sato, H; Sato, K; Yuda, F | 1 |
Akkasilpa, S; Avihingsanon, Y; Deesomchok, U; Osiri, M | 1 |
Gow, P; Kumar, S; Ng, J | 1 |
Wong, ML | 1 |
Hirayama, M; Iwanaga, T; Kobayashi, D; Maeda, T; Tamai, I | 1 |
Hosoyamada, M; Ichida, K; Shibasaki, T | 1 |
Atxotegi, J; Calabozo, M; Hernando, I; Nolla, JM; Perez-Ruiz, F | 1 |
Caldas, CA; Fuller, R | 1 |
Pascual, E; Sivera, F | 1 |
Brouwers, JR; Houtman, PM; Jansen, TL; Reinders, MK; van Roon, EN | 1 |
Cheng, CH; Fong, WP; Yu, Z | 1 |
Brouwers, JR; Delsing, J; Griep, EN; Hoekstra, M; Jansen, TL; Reinders, MK; van de Laar, MA; van Roon, EN | 1 |
Fujimori, S | 1 |
Ohno, I | 1 |
Brouwers, JR; Delsing, J; Haagsma, C; Jansen, TL; Reinders, MK; van de Laar, MA; van Roon, EN | 1 |
Bibert, S; Bonny, O; Firsov, D; Geering, K; Hess, SK; Horisberger, JD; Thorens, B | 1 |
Anker, SD; Doehner, W; Furuse, Y; Hisatome, I; Igawa, O; Ishida, K; Kato, M; Kinugasa, Y; Kinugawa, T; Ogino, K; Osaki, S; Shigemasa, C | 1 |
Bahrudin, U; Hamada, T; Hisatome, I; Hosoyamada, M; Ichida, K; Igawa, O; Iwai, C; Kuwabara, M; Kuwabara, N; Mizuta, E; Nindita, Y; Ninomiya, H; Shigemasa, C; Tsuchihashi, T; Urashima, S; Utami, SB; Yamada, K | 1 |
Gonzalez-Gay, MA; Hernandez-Baldizon, S; Herrero-Beites, AM; Perez-Ruiz, F | 1 |
Mamada, H; Nakanishi, T; Sato, M; Shirasaka, Y; Tamai, I; Wakayama, T | 1 |
Chernichovski, T; Engel, A; Grupper, A; Hillel, O; Schwartz, D; Schwartz, IF | 1 |
Hisatome, I | 1 |
Anzai, N; Endou, H; Enomoto, A; Fujimura, M; Miyazaki, H; Shin, HJ; Takeda, M | 1 |
Anzai, N; Chanluang, S; Endou, H; Fukutomi, T; He, X; Jutabha, P; Miura, D | 1 |
Kriegsmann, J; Lange, U; Müller-Ladner, U; Panzner, I; Tausche, AK | 1 |
Sun, WF; Xu, W; Zhang, XX | 1 |
Johnson, RJ; Mazali, FC; Mazzali, M | 1 |
Fujimori, S; Moromizato, H; Ooyama, H; Ooyama, K | 1 |
Koga, M; Koyama, H; Kurajoh, M; Moriwaki, Y; Shoji, T; Sumida, C; Tsutsumi, Z; Yamamoto, A; Yamamoto, T | 1 |
Dong, L; Huang, X; Pang, M; Wang, S; Zhou, L; Zhu, W | 1 |
Anzai, N; Nakanishi, T; Ohya, K; Shimada, S; Tamai, I | 1 |
Chen, YI; Huang, CS | 1 |
Chen, GL; Li, L; Na, S; Zhu, LR | 1 |
Joo, H; Joo, K; Jung, KH; Kwon, SR; Lim, MJ; Park, W | 1 |
Bombardier, C; Buchbinder, R; Edwards, CJ; Kydd, AS; Seth, R | 2 |
Chen, H; Ji, Z; Jiang, L; Ma, L; Wei, L; Yu, Q; Zhang, Z | 1 |
Akahoshi, Y; Ikeda, M; Shinozuka, K; Tabuchi, M; Uchida, S; Wakuda, H; Yamada, S | 1 |
Dalbeth, N; Robinson, PC | 1 |
Chen, X; Gao, Z; Xu, H; Zhan, L; Zheng, Y; Zhou, X | 1 |
Chuang, VT; Hirata, S; Kadowaki, D; Maruyama, T; Miyamoto, Y; Muraya, N; Narita, Y; Otagiri, M; Sakaguchi, S; Sato, K; Taguchi, K | 1 |
Huang, Y; Zhao, J | 1 |
Hanvivadhanakul, P; Wongdet, R | 1 |
Gui, D; Guo, Y; Jiang, Q; Wang, N | 1 |
Ahn, SO; Horiba, N; Kawabe, Y; Kim, BH; Kim, KH; Kiyokawa, J; Lee, KJ; Nakagawa, T; Ohtomo, S; Tanaka, J; Yamane, M | 1 |
Anzai, N; Hamada, T; Hirota, Y; Hisatome, I; Ikeda, N; Kato, M; Kuwabara, M; Maharani, N; Mishima, M; Miyazaki, S; Mizuta, E; Ninomiya, H; Notsu, T; Ogino, K; Onohara, T; Otani, N; Sugihara, S; Yoshida, A | 1 |
Chen, G; Jia, P | 1 |
Cathro, A; Corkill, M; Dalbeth, N; Frampton, C; Gardner, D; Grainger, R; Haslett, J; Kain, T; Kumar, R; Kumar, S; Metcalfe, S; Porter, D; Stamp, LK; Stebbings, S; Taylor, G; White, D; Wyeth, J | 1 |
Hifumi, A; Kojima, S; Ogawa, H; Soejima, H | 1 |
Arima, H; Hayashi, S; Ishizuka, A; Iwashima, Y; Kawano, Y; Kishida, M; Nakamura, S; Ohta, Y; Yoshihara, F | 1 |
Stamp, LK | 1 |
Chen, X; Su, J; Tian, J; Zhou, Q; Zhou, T; Zhu, J | 1 |
Chiang, SJ; Daimon, M; Ho, Y; Lin, HC; Uang, YS; Wang, CH; Wang, LH | 1 |
Gunic, E; Liu, S; Miner, JN; Tan, PK | 1 |
Kim, JW; Kwak, SG; Park, SH | 1 |
Li, LY; Lin, ZJ; Nie, AZ; Wang, Y; Zhang, B | 1 |
Chiu, HT; Chou, HW; Huang, HC; Kuo, CC; Ting, IW; Tsai, CW; Yeh, HC | 1 |
Cai, W; Liu, W; Liu, Y; Tang, L; Wang, J; Wu, J; Xie, Y; Xu, W; Zhang, S; Zhao, G | 1 |
Bao, H; Cheng, J; Liu, X; Peng, A; Qin, L; Song, Y; Wang, L; Yu, H; Zhou, X | 1 |
Gillen, M; Hall, J; Ito, Y; Liu, S; Shen, Z; Shiramoto, M; Yamamoto, A; Yan, X | 1 |
Abe, A; Anzai, N; Furihata, T; Ito, K; Kitagawara, Y; Mashino, T; Morio, H; Nakamura, S; Ohe, T; Okunushi, K; Sekine, S; Takahashi, K; Umezawa, R; Yasuda, D | 1 |
Chang, HW; Lan, YC; Lin, MH; Lin, YW; Wang, RY | 1 |
Bachettoni, A; Bartoli, M; Facchiano, F; Gutsaeva, DR; Malla, P; Martin, PM; Montemari, A; Powell, FL; Repossi, A; Ripandelli, G; Tawfik, A; Thounaojam, MC | 1 |
Deng, JX; Jie, LG; Qu, Y; Wu, J; Yu, QH; Zhang, YP | 1 |
Araujo, E; Baraf, HSB; Bayat, S; Cavallaro, A; Ellmann, H; Kleyer, A; Lell, M; Manger, B; Rech, J; Schenker, H; Schett, G; Simon, D; Tascilar, K | 1 |
Cheng, X; Cui, L; He, Y; Ji, A; Li, C; Li, H; Liang, N; Ma, L; Sun, M; Sun, R; Sun, W; Wang, C; Wu, X; Xu, T; Xue, X; Yuan, X; Zhang, H | 1 |
Chen, JS; Chiou, MJ; Chung, TT; Hsieh, AH; Kuo, CF; Lan, WC; Luo, SF; Tseng, WY; Wang, LC; Yu, KH | 1 |
Gao, H | 1 |
Kuriyama, S | 1 |
Han, H; Li, X; Tian, J; Yan, Z; Ye, F; Zhang, X | 1 |
Fushimi, M; Hosoya, T; Ohashi, T; Sano, T; Sasaki, T | 1 |
Hosoyamada, M; Kimura, Y; Kono, H; Onda, A; Tsukui, D; Yanagida, T | 1 |
Cao, Y; Chen, Y; Jiang, Y; Li, L; Li, Y; Pang, J; Wu, T; Zhao, Z; Zhou, P | 1 |
Sakaguchi, S | 1 |
Doi, Y; Fukae, S; Ikeda, S; Kawano, H; Koga, S; Maemura, K; Minami, T; Nakata, T; Tsuneto, A; Yonekura, T | 1 |
Li, Y; Liang, D; Liang, Z; Liu, H; Liu, Y; Su, M; Sun, L; Wang, D; Wei, Y; Yin, S; Zhang, G; Zhang, S; Zhao, J | 1 |
Ashizawa, N; Iwanaga, T; Kobashi, S; Matsumoto, K; Uda, J | 1 |
Becce, F; Budzik, JF; Ducoulombier, V; Lefebvre, A; Pascart, T | 1 |
Lee, YH; Song, GG | 1 |
Chen, JS; Liu, C; Liu, YF; Sun, B; Sun, JY; Wang, CZ; Wang, MM; Wang, MX; Wang, Z; Yang, QL; Zhang, YK | 1 |
Cai, M; Chen, S; Gao, X; Hu, H; Huang, L; Li, X; Liang, D; Liu, Y; Wu, Q; Xiao, C; Xie, Y; Yong, T | 1 |
Chen, Y; Cheng, X; Cui, L; Dalbeth, N; He, Y; Hu, S; Ji, A; Li, C; Li, H; Liu, Z; Lu, J; Ma, L; Qi, H; Ran, Z; Sun, M; Terkeltaub, R; Wang, C; Xue, X; Yan, F; Yu, Q; Yuan, X | 1 |
Cao, Y; Chen, J; Chen, Y; Feng, H; Guo, J; Kuang, P; Liao, H; Lin, C; Liu, J; Luo, J; Pang, J; Wu, T; Yang, Y; Yang, Z; Yuan, L; Zhang, Q; Zhao, Z; Zheng, F | 1 |
Chang, HH; Hsieh, SM; Lin, DP; Pai, HL; Su, YS; Sue, XY | 1 |
Iguchi, T; Ishiguro, C; Kajiyama, K; Kimura, R; Nakazato, Y; Oniyama, Y; Sawada, S; Shida, H; Uyama, Y | 1 |
Ashizawa, N; Chikamatsu, N; Iwanaga, T; Motoki, K; Sakai, M; Taniguchi, T; Yamano, K | 1 |
Hwang, BF; Kuo, YH; Lai, SW; Liao, KF; Liu, CS | 2 |
Kawada, T | 1 |
Gu, J; Han, Z; Ke, J; Lin, H; Pan, J | 1 |
Arima, H; Funakoshi, R; Iseki, K; Ishida, A; Kinjyo, K; Kochi, M; Kohagura, K; Nakamura, T; Ohya, Y; Sakima, A; Satoh, A; Tana, T; Yamazato, M; Zamami, R | 1 |
16 review(s) available for uric acid and benzbromarone
Article | Year |
---|---|
Urate excretion.
Topics: Acetohexamide; Animals; Benzbromarone; Benzofurans; Diuretics; Ethambutol; Halofenate; Humans; Mersalyl; Pan troglodytes; Probenecid; Salicylates; Sulfinpyrazone; Uric Acid; Zoxazolamine | 1977 |
Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.
Topics: Aspirin; Benzbromarone; Benzofurans; Drug Interactions; Fasting; Gout; Humans; Kidney Diseases; Kinetics; Lipid Metabolism; Pyrazinamide; Triglycerides; Uric Acid; Xanthine Oxidase | 1977 |
Treatment of the gout and other forms of crystal-induced arthritis.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzbromarone; Colchicine; Gout; Gout Suppressants; Humans; Indomethacin; Kidney; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1982 |
[Benzbromarone in the treatment of gout].
Topics: Benzbromarone; Benzofurans; Biological Availability; Chemical Phenomena; Chemistry; Gout; Half-Life; Humans; Time Factors; Uric Acid | 1980 |
[Management of hyperuricemia in diabetes].
Topics: Allopurinol; Benzbromarone; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Humans; Insulin Resistance; Probenecid; Uric Acid; Uricosuric Agents | 1997 |
[Molecular mechanism in biological transport in the kidney: Urate transporter URAT1].
Topics: Animals; Benzbromarone; Carrier Proteins; Humans; Hyperuricemia; Kidney Tubules; Organic Anion Transporters; Organic Cation Transport Proteins; Probenecid; RNA, Messenger; Transcription, Genetic; Uric Acid; Uricosuric Agents | 2006 |
[Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Topics: Allopurinol; Benzbromarone; Cardiovascular Diseases; Gout; Gout Suppressants; Humans; Hyperuricemia; Life Style; Patient Care Planning; Practice Guidelines as Topic; Renal Insufficiency; Uric Acid | 2008 |
[Uricosuric agent].
Topics: Allopurinol; Benzbromarone; Gout; Humans; Hyperuricemia; Kidney Tubules, Proximal; Organic Anion Transporters; Organic Cation Transport Proteins; Uric Acid; Uricosuric Agents | 2008 |
[Impact of serum uric acid level on the cardiovascular system as a risk factor].
Topics: Adipokines; Benzbromarone; Cardiovascular Diseases; Hyperuricemia; Kidney; Organic Anion Transporters; Organic Cation Transport Proteins; Oxidation-Reduction; Probenecid; Renal Tubular Transport, Inborn Errors; Risk Factors; Uric Acid; Uricosuric Agents; Urinary Calculi | 2010 |
[Gout - regardless of therapeutic options a "forgotten" disease].
Topics: Allopurinol; Arthritis, Gouty; Benzbromarone; Combined Modality Therapy; Cytokines; Europe; Febuxostat; Gout; Gout Suppressants; Guideline Adherence; Humans; Inflammasomes; Interleukin-1; Long-Term Care; Probenecid; Signal Transduction; Thiazoles; Uric Acid | 2011 |
Allopurinol for chronic gout.
Topics: Allopurinol; Benzbromarone; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Probenecid; Randomized Controlled Trials as Topic; Thiazoles; Uric Acid | 2014 |
Uricosuric medications for chronic gout.
Topics: Adult; Aged; Allopurinol; Benzbromarone; Chronic Disease; Controlled Clinical Trials as Topic; Female; Gout; Humans; Male; Middle Aged; Probenecid; Randomized Controlled Trials as Topic; Uric Acid; Uricosuric Agents | 2014 |
Advances in pharmacotherapy for the treatment of gout.
Topics: Adrenal Cortex Hormones; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzbromarone; Clinical Trials, Phase III as Topic; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Polyethylene Glycols; Probenecid; Thiazoles; Urate Oxidase; Uric Acid | 2015 |
Major unanswered questions in the clinical gout field.
Topics: Allopurinol; Benzbromarone; Colchicine; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Patient Care Planning; Probenecid; Renal Insufficiency, Chronic; Uric Acid; Uricosuric Agents | 2017 |
Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Benzothiazoles; Drug Interactions; Febuxostat; Female; Gout; Humans; Hyperuricemia; Male; Uric Acid; Uricosuric Agents | 2020 |
Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: A network meta-analysis of randomized controlled trials.
Topics: Benzbromarone; Benzothiazoles; Febuxostat; Gout; Gout Suppressants; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Treatment Outcome; Uric Acid; Uricosuric Agents | 2022 |
43 trial(s) available for uric acid and benzbromarone
Article | Year |
---|---|
[Hypouricemic effect of benzbromarone especially in kidney failure].
Topics: Adolescent; Adult; Aged; Benzbromarone; Benzofurans; Clinical Trials as Topic; Depression, Chemical; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Uric Acid | 1978 |
[Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].
Topics: Benzbromarone; Clinical Trials as Topic; Drug Evaluation; Gout; Humans; Male; Uric Acid | 1977 |
[Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
Topics: Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Female; Humans; Male; Middle Aged; Uric Acid | 1979 |
[Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
Topics: Adult; Allopurinol; Benzbromarone; Benzofurans; Drug Combinations; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides; Uric Acid | 1979 |
[The uricosuric effect of benzbromaron and probenecid under fasting conditions (author's transl)].
Topics: Benzbromarone; Benzofurans; Dose-Response Relationship, Drug; Fasting; Female; Humans; Kidney Tubules; Male; p-Aminohippuric Acid; Probenecid; Uric Acid | 1978 |
[The effect of benzbromarone on fasting-hyperuricemia as a model (author's transl)].
Topics: Adolescent; Adult; Benzbromarone; Benzofurans; Fasting; Female; Humans; Male; Middle Aged; Obesity; Probenecid; Purines; Uric Acid | 1978 |
[Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
Topics: Adult; Allopurinol; Benzbromarone; Benzofurans; Clinical Trials as Topic; Drug Combinations; Female; Gout; Humans; Male; Metabolic Clearance Rate; Middle Aged; Uric Acid | 1976 |
[Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
Topics: Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Calcium; Citrates; Creatinine; Glomerular Filtration Rate; Gout; Humans; Magnesium; Male; Middle Aged; Natriuresis; Sodium; Uric Acid | 1977 |
[Effect of benzbromarone in 100mg and 50mg doses on healthy subjects].
Topics: Administration, Oral; Analysis of Variance; Benzbromarone; Benzofurans; Humans; Male; Uric Acid | 1977 |
[Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone].
Topics: Adolescent; Adult; Benzbromarone; Benzofurans; Fasting; Female; Gout; Humans; Male; Middle Aged; Starvation; Uric Acid | 1976 |
[Effectiveness and tolerance of long-term uricosuric treatment].
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Benzbromarone; Dose-Response Relationship, Drug; Drug Combinations; Female; Gout; Humans; Kidney Calculi; Male; Middle Aged; Uric Acid | 1990 |
Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone.
Topics: Adult; Benzbromarone; Benzofurans; Humans; Hydroxylation; Inactivation, Metabolic; Male; Protein Binding; Purines; Uric Acid | 1988 |
[Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
Topics: Adult; Aged; Benzbromarone; Benzofurans; Clinical Trials as Topic; Gout; Humans; Male; Middle Aged; Uric Acid | 1980 |
Benzbromarone as a long-term uricosuric agent.
Topics: Benzbromarone; Benzofurans; Clinical Trials as Topic; Follow-Up Studies; Gout; Humans; Uric Acid | 1980 |
The action of benzbromarone in relation to age, sex and accompanying diseases.
Topics: Benzbromarone; Benzofurans; Body Height; Body Weight; Clinical Trials as Topic; Female; Follow-Up Studies; Gout; Humans; Male; Uric Acid | 1980 |
Benzbromarone therapy in hyperuricaemia.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Benzbromarone; Benzofurans; Clinical Trials as Topic; Creatinine; Female; Humans; Male; Middle Aged; Uric Acid | 1981 |
Benzbromarone therapy in hyperuricaemia; comparison with allopurinol and probenecid.
Topics: Adult; Allopurinol; Benzbromarone; Benzofurans; Clinical Trials as Topic; Female; Humans; Male; Placebos; Probenecid; Uric Acid | 1981 |
[The effect on uric acid and other laboratory parameters. A long-term study].
Topics: Allopurinol; Benzbromarone; Benzofurans; Clinical Trials as Topic; Gout; Humans; Uric Acid | 1982 |
[Prevention of urinary calculi by means of a benzbromarone-citrate combination].
Topics: Adult; Aged; Benzbromarone; Benzofurans; Circadian Rhythm; Citrates; Drug Combinations; Humans; Hydrogen-Ion Concentration; Middle Aged; Uric Acid; Urinary Calculi | 1980 |
The effect of benzbromarone on allopurinol/oxypurinol kinetics in patients with gout.
Topics: Adult; Aged; Allopurinol; Benzbromarone; Gout; Humans; Male; Middle Aged; Oxypurinol; Uric Acid | 1993 |
Effect of allopurinol and benzbromarone on the concentration of uridine in plasma.
Topics: Adult; Allopurinol; Benzbromarone; Dose-Response Relationship, Drug; Gout; Gout Suppressants; Humans; Male; Middle Aged; Purines; Pyrimidines; Time Factors; Uric Acid; Uricosuric Agents; Uridine; Xanthine Oxidase | 1997 |
Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
Topics: Adult; Aged; Allopurinol; Benzbromarone; Chronic Disease; Drug Administration Schedule; Gout; Gout Suppressants; Humans; Male; Middle Aged; Prospective Studies; Uric Acid; Uricosuric Agents | 1998 |
Does a relationship exist between the urate pool in the body and lipid peroxidation during exercise?
Topics: Adult; Allantoin; Ascorbic Acid; Benzbromarone; Case-Control Studies; Exercise; Humans; Inosine Monophosphate; Lactates; Lipid Peroxidation; Male; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Uric Acid; Uricosuric Agents; Vitamin E | 2000 |
Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts.
Topics: Adult; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Risk Factors; Uric Acid; Uricosuric Agents | 2000 |
Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
Topics: Adult; Aged; Allopurinol; Benzbromarone; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gout; Humans; Male; Middle Aged; Probability; Statistics, Nonparametric; Treatment Outcome; Uric Acid; Uricosuric Agents; Urinalysis | 2002 |
Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Topics: Adult; Aged; Allopurinol; Benzbromarone; Crystallization; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Prospective Studies; Uric Acid | 2002 |
Benzbromarone therapy in management of refractory gout.
Topics: Adult; Allopurinol; Benzbromarone; Creatinine; Female; Gout; Humans; Incidence; Male; Metabolic Clearance Rate; Middle Aged; New Zealand; Treatment Outcome; Uric Acid | 2005 |
Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
Topics: Allopurinol; Benzbromarone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gout; Humans; Hyperuricemia; Male; Middle Aged; Probenecid; Uric Acid; Uricosuric Agents | 2007 |
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
Topics: Aged; Allopurinol; Benzbromarone; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Hypersensitivity; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Probenecid; Prospective Studies; Treatment Failure; Uric Acid | 2009 |
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
Topics: Aged; Allopurinol; Benzbromarone; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Oxypurinol; Patient Compliance; Prospective Studies; Treatment Outcome; Uric Acid; Uricosuric Agents | 2009 |
Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Topics: Aged; Benzbromarone; Double-Blind Method; Female; Heart Failure; Humans; Hyperuricemia; Male; Middle Aged; Treatment Outcome; Up-Regulation; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2010 |
[Assessment on the clinical efficacy and safety of xiezhuo chubi recipe in treating hyperuricemia].
Topics: Adolescent; Adult; Aged; Benzbromarone; Drugs, Chinese Herbal; Female; Humans; Hyperuricemia; Male; Middle Aged; Phytotherapy; Treatment Outcome; Uric Acid; Young Adult | 2011 |
Therapeutic strategy for efficient reduction of serum uric acid levels with allopurinol versus benzbromarone in hyperuricemic patients with essential hypertension - A randomized crossover study (terao study).
Topics: Aged; Aged, 80 and over; Allopurinol; Benzbromarone; Drug Administration Schedule; Drug Monitoring; Enzyme Inhibitors; Essential Hypertension; Female; Humans; Hypertension; Hyperuricemia; Kidney Function Tests; Male; Middle Aged; Organic Anion Transporters; Stroke Volume; Treatment Outcome; Uric Acid; Xanthine Oxidase | 2016 |
Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia.
Topics: Aged; Benzbromarone; Cross-Over Studies; Drug Therapy, Combination; Febuxostat; Female; Gout Suppressants; Humans; Hypertension; Hyperuricemia; Male; Middle Aged; Treatment Outcome; Uric Acid | 2017 |
Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study.
Topics: Allopurinol; Benzbromarone; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Population Surveillance; Risk Factors; Taiwan; Treatment Outcome; Uric Acid; Uricosuric Agents | 2017 |
Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study.
Topics: Aged; Alpha-Globulins; Benzbromarone; Febuxostat; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Hyperuricemia; Kidney Calculi; Male; Middle Aged; Pilot Projects; Prospective Studies; Renal Insufficiency, Chronic; Uric Acid; Uricosuric Agents | 2018 |
Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.
Topics: Administration, Oral; Adult; Aged; Benzbromarone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Organic Anion Transporters; Organic Cation Transport Proteins; Thioglycolates; Time Factors; Treatment Outcome; Triazoles; Uric Acid; Uricosuric Agents; Young Adult | 2018 |
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort.
Topics: Benzbromarone; Biomarkers; China; Dose-Response Relationship, Drug; Febuxostat; Follow-Up Studies; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Kidney; Male; Middle Aged; Prospective Studies; Treatment Outcome; Uric Acid; Uricosuric Agents | 2019 |
Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study.
Topics: Adult; Aged; Benzbromarone; Benzothiazoles; Double-Blind Method; Female; Gout; Humans; Hyperuricemia; Japan; Male; Middle Aged; Treatment Outcome; Uric Acid; Uricosuric Agents | 2020 |
Randomized, Open-Label, Cross-Over Comparison of the Effects of Benzbromarone and Febuxostat on Endothelial Function in Patients with Hyperuricemia.
Topics: Adiponectin; Aged; Arginine; Benzbromarone; Cross-Over Studies; Endothelium, Vascular; Febuxostat; Female; Gout Suppressants; Humans; Hyperemia; Hyperuricemia; Male; Middle Aged; Organic Anion Transporters; Organic Cation Transport Proteins; Treatment Outcome; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2020 |
Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion.
Topics: Allopurinol; Benzbromarone; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Prospective Studies; Treatment Outcome; Uric Acid | 2022 |
Uric acid-lowering therapy with benzbromarone in hypertension with asymptomatic hyperuricemia: a randomized study focusing left ventricular diastolic function.
Topics: Benzbromarone; Heart Failure; Humans; Hypertension; Hyperuricemia; Stroke Volume; Uric Acid | 2023 |
Urate-lowering drugs for chronic kidney disease with asymptomatic hyperuricemia and hypertension: a randomized trial.
Topics: Benzbromarone; Febuxostat; Gout Suppressants; Humans; Hypertension; Hyperuricemia; Renal Insufficiency, Chronic; Treatment Outcome; Uric Acid | 2023 |
149 other study(ies) available for uric acid and benzbromarone
Article | Year |
---|---|
Urate transport via human PAH transporter hOAT1 and its gene structure.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Biological Transport; Blotting, Western; Carbon Radioisotopes; Cell Line; Cloning, Molecular; Exons; Female; Gene Library; Gout; Humans; Kidney; Kidney Diseases; Organic Anion Transport Protein 1; p-Aminohippuric Acid; Probenecid; Protein Structure, Tertiary; Pyrazinamide; Sodium Salicylate; Uric Acid; Uricosuric Agents | 2003 |
Discovery of Dotinurad (FYU-981), a New Phenol Derivative with Highly Potent Uric Acid Lowering Activity.
Topics: | 2020 |
[The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
Topics: Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Dosage Forms; Female; Humans; Male; Middle Aged; Uric Acid; Uricosuric Agents | 1978 |
[The treatment of hyperuricemia after kidney transplantation].
Topics: Allopurinol; Azathioprine; Benzbromarone; Creatinine; Drug Interactions; Female; Humans; Kidney Transplantation; Male; Transplantation, Homologous; Uric Acid; Urinary Calculi | 1977 |
[Therapy of gout].
Topics: Allopurinol; Arteriosclerosis; Benzbromarone; Colchicine; Gout; Humans; Immobilization; Indomethacin; Uric Acid | 1979 |
[The effect of benzbromaron in gout patients with limited kidney function].
Topics: Adult; Aged; Benzbromarone; Benzofurans; Creatinine; Drug Evaluation; Gout; Humans; Kidney Diseases; Male; Middle Aged; Uric Acid | 1979 |
[Allomaron in hyperuricemia and gout].
Topics: Adolescent; Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Drug Combinations; Drug Evaluation; Female; Gout; Humans; Male; Middle Aged; Uric Acid | 1979 |
[Comparative study of uric acid concentration in serum and saliva of healthy or hyperuricemic subjects].
Topics: Benzbromarone; Benzofurans; Humans; Methods; Saliva; Uric Acid | 1977 |
[Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
Topics: Benzbromarone; Benzofurans; Diarrhea; Female; Gout; Humans; Kidney Calculi; Male; Nausea; Uric Acid | 1978 |
[Gout - a surgical problem].
Topics: Allopurinol; Benzbromarone; Female; Gout; Hand; Humans; Middle Aged; Patient Care Team; Uric Acid | 1978 |
Treatment of gout with alternate-day hypo-uricaemic drugs.
Topics: Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Female; Gout; Humans; Male; Middle Aged; Sulfinpyrazone; Uric Acid | 1978 |
[Long-term therapy with benzbromarone in uric arthritis].
Topics: Adult; Aged; Benzbromarone; Benzofurans; Diarrhea; Female; Gout; Humans; Leukopenia; Long-Term Care; Male; Middle Aged; Uric Acid | 1975 |
Protein binding to monosodium urate crystals and its effect on platelet degranulation. Influence of urate on connective tissue metabolism.
Topics: Acetylglucosaminidase; Benzbromarone; Connective Tissue; Glycosaminoglycans; Gout; Heparin; Hyaluronoglucosaminidase; Lysosomes; Models, Biological; Proteoglycans; Solubility; Synovial Fluid; Uric Acid | 1977 |
The pharmacology of the hypouricemic effect of benzbromarone.
Topics: Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Drug Interactions; Glomerular Filtration Rate; Kidney Tubules; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1977 |
[Mechanisms of action of benzbromarone. Study in 3 anephric subjects. Preliminary results in 3 cases].
Topics: Adult; Benzbromarone; Benzofurans; Glomerulonephritis; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Nephrectomy; Polycystic Kidney Diseases; Proteinuria; Pyelonephritis; Renal Dialysis; Uric Acid | 1977 |
[Isolated or combined drug therapy of hyperuricemia?].
Topics: Allopurinol; Benzbromarone; Drug Therapy, Combination; Gout; Humans; Uric Acid; Uricosuric Agents | 1977 |
[Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)].
Topics: Adult; Allantoin; Benzbromarone; Benzofurans; Female; Humans; Male; Uric Acid; Uricosuric Agents | 1977 |
[Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Topics: Benzbromarone; Benzofurans; Gout; Humans; Uric Acid | 1976 |
Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.
Topics: Adult; Aged; Arthritis; Benzbromarone; Benzofurans; Chemical Phenomena; Chemistry; Chronic Disease; Gout; Humans; Hydrochlorothiazide; Kinetics; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |
[Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
Topics: Allopurinol; Benzbromarone; Benzofurans; Drug Combinations; Gout; Humans; Time Factors; Uric Acid | 1976 |
The pharmacology of hypouricemic effect of benzbromarone.
Topics: Adult; Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Creatinine; Female; Gout; Humans; Male; Middle Aged; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1975 |
[Which uric acid value is in need of treatment?].
Topics: Allopurinol; Benzbromarone; Citrates; Coronary Disease; Gout; Humans; Hyperlipidemias; Hypertension; Hypoxanthine Phosphoribosyltransferase; Kidney Diseases; Lesch-Nyhan Syndrome; Obesity; Uric Acid | 1976 |
Circadian rhythm of plasma uric acid and handling stress-induced hyperuricemia in conscious cebus monkeys.
Topics: Animals; Benzbromarone; Cebus; Circadian Rhythm; Diazepam; Female; Gum Arabic; Handling, Psychological; Male; Probenecid; Stress, Physiological; Uric Acid | 1992 |
[Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
Topics: Allopurinol; Benzbromarone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gout; Humans; Male; Uric Acid | 1992 |
Two cases in whom pyrazinamide does not inhibit the uricosuric action of benzbromarone.
Topics: Adult; Benzbromarone; Diabetes Mellitus, Type 2; Drug Interactions; Female; Humans; Kidney; Kidney Diseases; Male; Pyrazinamide; Uric Acid | 1992 |
Changes caused by ethanol intake on metabolism of hypouricemic agents (combination of allopurinol and benzbromarone).
Topics: Adult; Alcohol Drinking; Allopurinol; Benzbromarone; Ethanol; Humans; Male; Middle Aged; Time Factors; Uric Acid | 1991 |
Pharmacokinetics of benzbromarone: evidence for a biliary-intestinal-biliary recirculation.
Topics: Benzbromarone; Bile; Chromatography, High Pressure Liquid; Humans; Intestines; Uric Acid | 1991 |
Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
Topics: Absorption; Adult; Benzbromarone; Humans; Kidney Tubules; Male; Middle Aged; Models, Biological; Pyrazinamide; Uric Acid | 1991 |
[Uric acid and arterial hypertension. II. Evaluation of uric acid transport in the nephrons in primary arterial hypertension].
Topics: Adult; Benzbromarone; Biological Transport; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Function Tests; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Pyrazinamide; Uric Acid | 1991 |
[Uric acid level in blood donors of southern Germany--almost constant since 1971].
Topics: Adult; Arthritis, Gouty; Benzbromarone; Benzimidazoles; Blood Donors; Cross-Sectional Studies; Female; Germany; Gout; Humans; Incidence; Male; Uric Acid; Uricosuric Agents | 1991 |
Acute uric acid nephropathy in two gouty patients with moderate hyperuricemia and high urine acidity.
Topics: Acute Kidney Injury; Benzbromarone; Glomerular Filtration Rate; Gout; Humans; Male; Middle Aged; Uric Acid | 1990 |
[Clinical studies on hyperuricemia and gout after transplantation].
Topics: Adult; Allopurinol; Analgesics; Benzbromarone; Female; Gout; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Uric Acid | 1990 |
The influence of benzbromarone and its combination with hydrochlorothiazide on renal excretion of uric acid and electrolytes.
Topics: Administration, Oral; Adult; Benzbromarone; Female; Humans; Hydrochlorothiazide; Male; Metabolic Clearance Rate; Potassium; Sodium; Time Factors; Uric Acid | 1990 |
Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
Topics: Benzbromarone; Benzofurans; Glomerular Filtration Rate; Humans; Kidney Tubules; Male; Pyrazinamide; Uric Acid | 1990 |
[Effect of exercise on urate excretion].
Topics: Adult; Benzbromarone; Depression, Chemical; Exercise; Glomerular Filtration Rate; Humans; Kidney; Male; Probenecid; Pyrazinamide; Uric Acid | 1989 |
Cause of persistent hypouricemia in outpatients.
Topics: Benzbromarone; Female; Hematuria; Humans; Male; Outpatients; Patients; Pyrazinamide; Uric Acid | 1989 |
Inhibition of purine catabolism by benzbromarone in isolated rat liver cells. Comparison with allopurinol and probenecid.
Topics: Allopurinol; Animals; Benzbromarone; Benzofurans; In Vitro Techniques; Liver; Male; Probenecid; Purines; Rats; Rats, Inbred Strains; Uric Acid | 1988 |
Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
Topics: Adult; Benzbromarone; Benzofurans; Biological Transport, Active; Female; Humans; Hypoxanthine; Hypoxanthines; Kidney; Male; Probenecid; Purines; Pyrazinamide; Uric Acid; Xanthine; Xanthines | 1988 |
Renal hypouricemia due to an isolated renal defect of urate transport.
Topics: Adult; Benzbromarone; Humans; Kidney; Kidney Diseases; Male; Pyrazinamide; Uric Acid | 1988 |
[Effect of an allopurinol/benzbromaron preparation on the composition of urine in a circadian course].
Topics: Adult; Allopurinol; Benzbromarone; Benzofurans; Calcium Oxalate; Circadian Rhythm; Drug Therapy, Combination; Female; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Male; Uric Acid | 1987 |
Drug interactions with urate excretion in man.
Topics: Adult; Ampicillin; Benzbromarone; Benzofurans; Drug Interactions; Humans; Kidney; Kinetics; Male; Probenecid; Pyrazinamide; Uric Acid | 1987 |
[The effect of benzbromarone and its combination with hydrochlorothiazide on the renal excretion of uric acid and electrolytes].
Topics: Adult; Benzbromarone; Benzofurans; Female; Humans; Hydrochlorothiazide; Kidney; Male; Potassium; Sodium; Uric Acid | 1986 |
Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone.
Topics: Adult; Allopurinol; Benzbromarone; Benzofurans; Creatinine; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Oxypurinol; Pyrimidines; Uric Acid | 1986 |
Hereditary renal hypouricemia in children.
Topics: Benzbromarone; Child; Child, Preschool; Creatinine; Humans; Kidney Diseases; Kidney Tubules; Metabolic Clearance Rate; Pyrazinamide; Uric Acid | 1985 |
Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?
Topics: Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Creatinine; Drug Therapy, Combination; Glomerular Filtration Rate; Gout; Humans; Male; Middle Aged; Oxypurinol; Pyrimidines; Uric Acid | 1984 |
[Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions].
Topics: Adult; Allopurinol; Benzbromarone; Benzofurans; Depression, Chemical; Diet; Erythrocytes; Female; Humans; Kidney; Male; Orotic Acid; Time Factors; Uric Acid | 1983 |
[A case of familial renal hypouricemia associated with bladder cancer].
Topics: Aged; Benzbromarone; Carcinoma, Transitional Cell; Humans; Male; Probenecid; Pyrazinamide; Renal Tubular Transport, Inborn Errors; Uric Acid; Urinary Bladder Neoplasms | 1984 |
[Pharmacotherapeutical action on arteriosclerotic vascular diseases with benzarone (author's transl)].
Topics: Arteriosclerosis; Benzbromarone; Benzofurans; Cholesterol; Factor VIII; Humans; Intermittent Claudication; Male; Middle Aged; Plasminogen; Triglycerides; Uric Acid | 1980 |
[Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
Topics: Allopurinol; Benzbromarone; Benzofurans; Drug Therapy, Combination; Fatty Liver, Alcoholic; Gout; Humans; Hypoxanthine; Hypoxanthines; Uric Acid; Xanthine; Xanthines | 1983 |
[Variations in fecal elimination of uric acid in 8 patients treated with benzbromarone].
Topics: Adult; Benzbromarone; Benzofurans; Feces; Humans; Middle Aged; Uric Acid | 1983 |
[Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
Topics: Allopurinol; Benzbromarone; Benzofurans; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Gout; Humans; Uric Acid | 1983 |
Hypouricemia due to renal urate wasting. Two types of tubular transport defect.
Topics: Adult; Benzbromarone; Biological Transport; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney Tubules, Proximal; Middle Aged; Pyrazinamide; Uric Acid | 1982 |
[Treatment of hyperuricemia].
Topics: Allopurinol; Benzbromarone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Uric Acid | 1981 |
Ten years' experience with benzbromarone in the management of gout and hyperuricaemia.
Topics: Adult; Aged; Benzbromarone; Benzofurans; Female; Follow-Up Studies; Gout; Humans; Male; Middle Aged; Time Factors; Uric Acid | 1981 |
[Uric acid-induced diseases. 2. Therapy].
Topics: Allopurinol; Benzbromarone; Benzothiadiazines; Diuretics; Gout; Humans; Purines; Sodium Chloride Symporter Inhibitors; Uric Acid; Urinary Calculi | 1980 |
Renal handling of uric acid in normal and gouty subject: evidence for a 4-component system.
Topics: Absorption; Benzbromarone; Blood Proteins; Female; Gout; Humans; In Vitro Techniques; Kidney; Kidney Tubules; Male; Models, Biological; Protein Binding; Pyrazinamide; Secretory Rate; Temperature; Uric Acid | 1980 |
Isolated defect in postsecretory reabsorption of uric acid.
Topics: Absorption; Adult; Benzbromarone; Female; Humans; Metabolic Diseases; Pyrazinamide; Uric Acid | 1980 |
[Efficacy and tolerance of a new benzbromarone preparation].
Topics: Benzbromarone; Benzofurans; Gout; Humans; Hydrogen-Ion Concentration; Uric Acid; Urine | 1980 |
Determination of tubular secretion of urate in healthy and gouty men.
Topics: Adult; Benzbromarone; Female; Gout; Humans; Kidney Tubules; Male; Reference Values; Uric Acid | 1980 |
[Mechanism of fasting hyperuricemia].
Topics: Adolescent; Adult; Aged; Benzbromarone; Fasting; Female; Humans; Kidney; Male; Middle Aged; Nucleic Acids; Uric Acid | 1980 |
[Clinical followup of the uricosuric drug--benzbromaron (author's transl)].
Topics: Benzbromarone; Benzofurans; Humans; Uric Acid | 1980 |
[Erythrocyte uric acid in the non-gouty subject].
Topics: Benzbromarone; Erythrocytes; Humans; Obesity; Renal Dialysis; Uric Acid | 1980 |
Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome?
Topics: Benzbromarone; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fenofibrate; Gout; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney; Kinetics; Syndrome; Uric Acid; Uricosuric Agents | 1994 |
Pharmacologic evaluation of the renal handling of uric acid and oxypurines.
Topics: Adult; Benzbromarone; Biological Transport; Humans; Hypoxanthine; Hypoxanthines; Kidney Tubules; Male; Probenecid; Pyrazinamide; Uric Acid; Xanthines | 1994 |
Renal hypouricemia: incomplete combined defect.
Topics: Adult; Benzbromarone; Calcium; Humans; Male; Nephrosis, Lipoid; Probenecid; Pyrazinamide; Uric Acid | 1994 |
Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study.
Topics: Benzbromarone; Creatinine; Cyclosporine; Drug Interactions; Female; Graft Survival; Humans; Kidney Function Tests; Kidney Transplantation; Male; Prospective Studies; Uric Acid | 1994 |
[The use of Allomaron in treating hyperuricemia].
Topics: Adult; Allopurinol; Arthritis, Gouty; Benzbromarone; Creatinine; Drug Combinations; Drug Evaluation; Female; Gout; Humans; Male; Middle Aged; Time Factors; Uric Acid | 1994 |
[Evaluation of uric acid transport in nephrons of patients with calcium nephrolithiasis and hyperuricosuria].
Topics: Absorption; Adult; Benzbromarone; Calcium; Female; Humans; Kidney Calculi; Male; Middle Aged; Nephrons; Pyrazinamide; Recurrence; Uric Acid | 1993 |
Renal hypouricemia due to enhanced tubular secretion of urate associated with urolithiasis: successful treatment of urolithiasis by alkalization of urine K+, Na(+)-citrate.
Topics: Benzbromarone; Citrates; Creatinine; Female; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Kidney Tubules; Middle Aged; Probenecid; Pyrazinamide; Uric Acid; Urinary Calculi | 1993 |
Benzbromarone hydroxylation in man: defective formation of the 6-hydroxybenzbromarone metabolite.
Topics: Administration, Oral; Adult; Benzbromarone; Diet; Female; Humans; Hydroxylation; Male; Phenotype; Uric Acid | 1993 |
[A study on uric acid excretion in patients with hypouricemia].
Topics: Acute Kidney Injury; Benzbromarone; Diabetes Complications; Diabetes Mellitus; Female; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Pyrazinamide; Uric Acid | 1993 |
Renal handling of urate in a patient with familial juvenile gouty nephropathy.
Topics: Adolescent; Benzbromarone; Female; Genes, Dominant; Gout; Gout Suppressants; Humans; Kidney; Kidney Failure, Chronic; Male; Pedigree; Probenecid; Pyrazinamide; Renal Agents; Uric Acid; Uricosuric Agents | 1996 |
Uric acid transport in fanconi syndrome with marked renal hypouricemia: analysis using pyrazinamide and benzbromarone.
Topics: Adolescent; Benzbromarone; Fanconi Syndrome; Humans; Kidney; Male; Pyrazinamide; Time Factors; Uric Acid; Uricosuric Agents | 1996 |
Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
Topics: Aged; Benzbromarone; Biological Transport; Biphenyl Compounds; Carbon Radioisotopes; Diuretics; Ethambutol; Humans; Imidazoles; Kidney Cortex; Kidney Neoplasms; Kinetics; Losartan; Microvilli; Middle Aged; Probenecid; Pyrazinamide; Salicylates; Salicylic Acid; Sulfinpyrazone; Tetrazoles; Ticrynafen; Uric Acid; Uricosuric Agents | 1997 |
Two cases of renal hypouricemia with nephrolithiasis.
Topics: Adult; Benzbromarone; Creatinine; Humans; Kidney Calculi; Kidney Tubules; Male; Middle Aged; Pyrazinamide; Uric Acid; Uricosuric Agents | 1997 |
Gout due to xanthine derivatives.
Topics: Allopurinol; Aminophylline; Asthma; Benzbromarone; Bronchodilator Agents; Drug Therapy, Combination; Female; Gout; Humans; Middle Aged; Probenecid; Theophylline; Uric Acid; Uricosuric Agents | 1997 |
Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
Topics: Adult; Benzbromarone; Female; Humans; Liver Cirrhosis; Middle Aged; Uric Acid; Uricosuric Agents | 1995 |
Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout.
Topics: Adult; Allopurinol; Benzbromarone; Calcifediol; Calcitriol; Calcium; Gout; Gout Suppressants; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphates; Reference Values; Uric Acid; Uricosuric Agents | 1998 |
Hematuria in patients with renal hypouricemia.
Topics: Adult; Aged; Aged, 80 and over; Benzbromarone; Creatinine; Female; Hematuria; Humans; Kidney Diseases; Male; Metabolism, Inborn Errors; Middle Aged; Probenecid; Pyrazinamide; Renal Agents; Uric Acid | 1998 |
How should we treat tophaceous gout in patients with allopurinol hypersensitivity?
Topics: Adolescent; Adult; Aged; Allopurinol; Benzbromarone; Creatinine; Drug Hypersensitivity; Gout; Gout Suppressants; Humans; Hypoxanthine Phosphoribosyltransferase; Kidney Failure, Chronic; Male; Middle Aged; Purine-Pyrimidine Metabolism, Inborn Errors; Uric Acid | 1998 |
Apoptosis of tubular epithelial cells in familial juvenile gouty nephropathy.
Topics: Adult; Apoptosis; Benzbromarone; Biopsy; Biotin; Deoxyuracil Nucleotides; DNA Fragmentation; Family Health; Female; Genes, Dominant; Glomerulosclerosis, Focal Segmental; Gout; Humans; Kidney Failure, Chronic; Kidney Tubules, Proximal; Male; Middle Aged; Pedigree; Probenecid; Staining and Labeling; Uremia; Uric Acid; Uricosuric Agents | 1998 |
Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
Topics: Absorption; Acute Kidney Injury; Adult; Anti-Inflammatory Agents; Benzbromarone; Fludrocortisone; Gout; Humans; Kidney Tubules; Lypressin; Male; Probenecid; Pyrazinamide; Receptors, Vasopressin; Renal Agents; Terlipressin; Uric Acid; Uricosuric Agents | 1998 |
[Gout: physiopathology, diagnosis, course, treatment].
Topics: Adult; Aged; Allopurinol; Arthritis, Gouty; Benzbromarone; Diagnosis, Differential; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Probenecid; Synovial Fluid; Uric Acid; Uricosuric Agents | 1998 |
A case of exercise-induced acute renal failure in a patient with enhanced renal hypouricaemia.
Topics: Acute Kidney Injury; Adult; Benzbromarone; Exercise; Humans; Male; Pyrazinamide; Renal Tubular Transport, Inborn Errors; Uric Acid; Uricosuric Agents | 2000 |
[Hyperuricemia and gout--treatment].
Topics: Acute Disease; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Colchicine; Drug Therapy, Combination; Glucocorticoids; Gout; Gout Suppressants; Humans; Kidney Calculi; Kidney Diseases; Probenecid; Time Factors; Uric Acid; Uricosuric Agents | 2002 |
Fulminant hepatic failure associated with benzbromarone treatment: a case report.
Topics: Benzbromarone; Female; Humans; Liver Failure; Middle Aged; Uric Acid; Uricosuric Agents | 2002 |
A case of exercise-induced acute renal failure in a patient with idiopathic renal hypouricemia developed during antihypertensive therapy with losartan and trichlormethiazide.
Topics: Acute Kidney Injury; Antihypertensive Agents; Benzbromarone; Blood Cell Count; Creatinine; Diuretics; Drug Therapy, Combination; Exercise; Humans; Hypertension; Kidney; Kidney Function Tests; Losartan; Male; Martial Arts; Middle Aged; Pyrazinamide; Sodium Chloride Symporter Inhibitors; Trichlormethiazide; Uric Acid | 2003 |
The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Topics: Allopurinol; Benzbromarone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Uric Acid; Uricosuric Agents | 2004 |
Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
Topics: Allopurinol; Anti-Inflammatory Agents; Benzbromarone; Chronic Disease; Colchicine; Drug Hypersensitivity; Gout; Humans; Uric Acid; Uricosuric Agents | 2005 |
Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
Topics: Animals; Benzbromarone; Carrier Proteins; Drug Interactions; Enzyme Inhibitors; Humans; Kidney; Metabolic Clearance Rate; Organic Anion Transporters; Organic Cation Transport Proteins; Oxypurinol; Solute Carrier Family 22 Member 5; Symporters; Uric Acid; Uricosuric Agents; Xenopus laevis | 2005 |
Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Arthritis, Gouty; Benzbromarone; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Gout Suppressants; Humans; Life Style; Middle Aged; Predictive Value of Tests; Prospective Studies; Secondary Prevention; Time Factors; Uric Acid | 2006 |
Excellent response to the clinical treatment of tophaceous gout.
Topics: Aged; Allopurinol; Benzbromarone; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Kidney Failure, Chronic; Male; Treatment Outcome; Uric Acid; Uricosuric Agents | 2007 |
Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout.
Topics: Adult; Aged; Benzbromarone; Chronic Disease; Crystallization; Follow-Up Studies; Gout; Gout Suppressants; Humans; Knee Joint; Male; Metatarsophalangeal Joint; Middle Aged; Statistics, Nonparametric; Synovial Fluid; Time Factors; Treatment Outcome; Uric Acid | 2007 |
Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells.
Topics: Benzbromarone; Cell Line; Flavonoids; Humans; Kidney; Organic Anion Transporters; Organic Cation Transport Proteins; Probenecid; Sulfinpyrazone; Transfection; Uric Acid; Uricosuric Agents | 2007 |
Mouse GLUT9: evidences for a urate uniporter.
Topics: Animals; Benzbromarone; Biological Transport; Chlorides; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 2; Kinetics; Losartan; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Nephrons; Oocytes; Organic Anion Transporters; Phloretin; Protein Isoforms; RNA, Messenger; Sodium; Species Specificity; Uric Acid; Uricosuric Agents; Xenopus laevis | 2009 |
Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzbromarone; Cell Line; Humans; Kidney; Losartan; Organic Anion Transporters; Organic Cation Transport Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uric Acid; Uricosuric Agents | 2010 |
Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout.
Topics: Allopurinol; Benzbromarone; Cohort Studies; Creatinine; Follow-Up Studies; Gout; Humans; Hyperuricemia; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Colic; Risk Factors; Time Factors; Uric Acid; Uricosuric Agents; Urolithiasis | 2010 |
Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats.
Topics: Animals; Anion Transport Proteins; Benzbromarone; Biological Transport; Epithelial Cells; Female; Humans; Immunohistochemistry; Kidney; Kinetics; Lactates; Male; Microvilli; Oocytes; Pyrazinamide; Rats; Rats, Sprague-Dawley; Rats, Wistar; Uric Acid; Xenopus laevis | 2011 |
Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats.
Topics: Allopurinol; Animals; Aorta; Arginine; Benzbromarone; Biological Transport; Blood Pressure; Cationic Amino Acid Transporter 1; Disease Models, Animal; Hyperuricemia; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxonic Acid; Phosphorylation; Protein Kinase C-alpha; Rats; Rats, Wistar; Tyrosine; Uric Acid; Uricosuric Agents | 2011 |
Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Benzothiazoles; Biological Transport; Captopril; Cells, Cultured; Dogs; Enalapril; Indomethacin; Inhibitory Concentration 50; Organic Anion Transporters; Organic Cation Transport Proteins; Phenylbutazone; Probenecid; Pyridines; Salicylates; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 2011 |
Human urate transporter 1 (hURAT1) mediates the transport of orotate.
Topics: Animals; Benzbromarone; Biological Transport; Carrier Proteins; Cells, Cultured; HEK293 Cells; Humans; Kidney; Oocytes; Organic Anion Transporters; Organic Cation Transport Proteins; Orotic Acid; Uric Acid; Uricosuric Agents; Xenopus | 2011 |
Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.
Topics: Allopurinol; Animals; Benzbromarone; Cell Proliferation; Cyclosporine; Enzyme Inhibitors; Fibrosis; Hyperuricemia; Immunohistochemistry; Kidney; Kidney Diseases; Male; Osteopontin; Random Allocation; Rats; Rats, Sprague-Dawley; Uric Acid; Uricosuric Agents; Vascular Endothelial Growth Factor A; Xanthine Oxidase | 2012 |
Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
Topics: Benzbromarone; Female; Glomerular Filtration Rate; Humans; Hyperuricemia; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome; Uric Acid; Uricosuric Agents | 2011 |
Relationship between serum allantoin and urate in healthy subjects and effects of benzbromarone in gout patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Allantoin; Benzbromarone; Biomarkers; Case-Control Studies; Creatinine; Deoxyguanosine; Dinoprost; Gout; Humans; Hyperuricemia; Japan; Male; Middle Aged; Oxidative Stress; Time Factors; Treatment Outcome; Uric Acid; Uricosuric Agents | 2012 |
Anti-inflammatory and immunomodulatory effects of iridoid glycosides from Paederia scandens (LOUR.) MERRILL (Rubiaceae) on uric acid nephropathy rats.
Topics: Actins; Allopurinol; Animals; Anti-Inflammatory Agents; Benzbromarone; Chemokine CCL2; Cyclopentane Monoterpenes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glucosides; Immunologic Factors; Iridoid Glycosides; Kidney; Kidney Diseases; Male; Medicine, Chinese Traditional; Pyrans; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Rubiaceae; Transcription Factor RelA; Uric Acid | 2012 |
Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.
Topics: Animals; Benzbromarone; Cells, Cultured; Dogs; Fluorescent Antibody Technique; Glucose Transport Proteins, Facilitative; Humans; Kidney; Lactic Acid; Madin Darby Canine Kidney Cells; Niacin; Oocytes; Organic Anion Transporters; Organic Cation Transport Proteins; Pyrazinamide; Uric Acid; Uricosuric Agents; Vasodilator Agents; Xenopus laevis | 2013 |
New approach to assess bioequivalence parameters using generalized gamma mixed-effect model (model-based asymptotic bioequivalence test).
Topics: Algorithms; Benzbromarone; Ciprofloxacin; Computer Simulation; Cross-Over Studies; Humans; Male; Models, Statistical; Monte Carlo Method; Multivariate Analysis; Therapeutic Equivalency; Uric Acid | 2014 |
[Effect of total saponin of Dioscorea on chronic hyperuricemia and expression of URAT1 in rats].
Topics: Animals; Anion Transport Proteins; Benzbromarone; Dioscorea; Gout Suppressants; Hyperuricemia; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Saponins; Uric Acid; Xanthine Oxidase | 2013 |
Prevention of comorbidity and acute attack of gout by uric acid lowering therapy.
Topics: Adult; Allopurinol; Antimetabolites; Benzbromarone; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Thiazoles; Uric Acid; Uricosuric Agents; Urolithiasis | 2014 |
Influence of urate-lowering therapies on renal handling of uric acid.
Topics: Adult; Antihypertensive Agents; Benzbromarone; Case-Control Studies; Creatinine; Glomerular Filtration Rate; Gout; Humans; Hypertension; Kidney; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2016 |
Is hyperuricemia a risk factor for arteriosclerosis? Uric acid and arteriosclerosis in apolipoprotein e-deficient mice.
Topics: Aging; Allopurinol; Animal Feed; Animals; Apolipoproteins E; Arteriosclerosis; Benzbromarone; Diet; Gene Expression Regulation; Gout Suppressants; Hyperuricemia; Male; Mice; Mice, Knockout; Risk Factors; Uric Acid; Uricosuric Agents | 2014 |
Activation of peripheral KCNQ channels relieves gout pain.
Topics: Action Potentials; Animals; Animals, Newborn; Arthritis; Benzbromarone; Cells, Cultured; CHO Cells; Cricetulus; Disease Models, Animal; Formaldehyde; Ganglia, Spinal; Hippocampus; Inflammation; KCNQ2 Potassium Channel; Male; Mice; Mice, Inbred Strains; Neurons; Rats; Rats, Sprague-Dawley; Uric Acid; Uricosuric Agents | 2015 |
Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment.
Topics: Antioxidants; Benzbromarone; Cell Line; Endothelial Cells; Free Radical Scavengers; Human Umbilical Vein Endothelial Cells; Humans; Hyperuricemia; Kidney; Oxidative Stress; Reactive Oxygen Species; Superoxides; Uric Acid | 2015 |
Salivary uric acid as a noninvasive biomarker for monitoring the efficacy of urate-lowering therapy in a patient with chronic gouty arthropathy.
Topics: Arthritis, Gouty; Benzbromarone; Biomarkers; Chronic Disease; Feasibility Studies; Humans; Hyperuricemia; Kidney; Male; Middle Aged; Saliva; Treatment Outcome; Uric Acid | 2015 |
Outcome of Treatment in Gouty Arthritis Patients: A Retrospective Study.
Topics: Alcohol Drinking; Allopurinol; Arthritis, Gouty; Benzbromarone; Female; Follow-Up Studies; Gout Suppressants; Humans; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Uric Acid; Uricosuric Agents | 2015 |
Chinese Herbal Formulas Si-Wu-Tang and Er-Miao-San Synergistically Ameliorated Hyperuricemia and Renal Impairment in Rats Induced by Adenine and Potassium Oxonate.
Topics: Adenine; Administration, Oral; Animals; Benzbromarone; Creatinine; Drug Synergism; Drugs, Chinese Herbal; Hyperuricemia; Kidney; Male; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Oxonic Acid; Plant Exudates; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase | 2015 |
Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
Topics: Animals; Benzbromarone; Cebus; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; HEK293 Cells; Humans; Male; Microsomes, Liver; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Oxazines; Protein Binding; Pyridines; Uric Acid; Uricosuric Agents | 2016 |
Effects of Uric Acid on the NO Production of HUVECs and its Restoration by Urate Lowering Agents.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzbromarone; Biphenyl Compounds; Cells, Cultured; Glucose Transport Proteins, Facilitative; Human Umbilical Vein Endothelial Cells; Humans; Irbesartan; Losartan; Monocarboxylic Acid Transporters; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Tetrazoles; Uric Acid; Uricosuric Agents | 2016 |
Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia.
Topics: Allopurinol; Animals; Benzbromarone; Fructose; Glucose Transporter Type 2; Glucose Transporter Type 5; Hyperuricemia; Intestinal Mucosa; Liver; Male; Rats; Uric Acid; Xanthine Oxidase | 2016 |
The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
Topics: Aged; Allopurinol; Benzbromarone; Comorbidity; Exanthema; Female; Gout; Gout Suppressants; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; New Zealand; Retrospective Studies; Uric Acid; Uricosuric Agents | 2016 |
A study comparing the safety and efficacy of febuxostat, allopurinol, and benzbromarone in Chinese gout patients: a retrospective cohort study
.
Topics: Adult; Allopurinol; Asian People; Benzbromarone; Biomarkers; China; Drug Dosage Calculations; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Uric Acid | 2017 |
Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout.
Topics: Adult; Animals; Benzbromarone; Biological Transport; Dose-Response Relationship, Drug; Gout; HEK293 Cells; Humans; Hyperuricemia; Inhibitory Concentration 50; Kinetics; Male; Molecular Targeted Therapy; Mutation; Organic Anion Transporters; Organic Cation Transport Proteins; Protein Binding; Rats; Uric Acid; Uricosuric Agents; Young Adult | 2017 |
Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database.
Topics: Allopurinol; Benzbromarone; Databases, Factual; Febuxostat; Gout; Gout Suppressants; Humans; Republic of Korea; Uric Acid | 2018 |
[Effect of Chinese herb chicory extract on expression of renal transporter Glut9 in rats with hyperuricemia].
Topics: Animals; Benzbromarone; Cichorium intybus; Drugs, Chinese Herbal; Hyperuricemia; Kidney; Male; Monosaccharide Transport Proteins; Plant Extracts; Rats; Rats, Sprague-Dawley; Uric Acid | 2017 |
Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study.
Topics: Aged; Allopurinol; Benzbromarone; Cohort Studies; Disease Progression; Drug Monitoring; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Incidence; Male; Middle Aged; Renal Insufficiency, Chronic; Taiwan; Uric Acid; Uricosuric Agents | 2018 |
Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor.
Topics: Benzbromarone; Biological Transport, Active; Carbon Radioisotopes; Drug Design; Gene Expression; HEK293 Cells; Humans; Methane; Organic Anion Transporters; Organic Cation Transport Proteins; Structure-Activity Relationship; Thioglycolates; Triazoles; Uric Acid; Uricosuric Agents | 2018 |
Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation.
Topics: Activation, Metabolic; Animals; Benzbromarone; Chemistry Techniques, Synthetic; HEK293 Cells; Hepatocytes; Humans; Mice; Microsomes, Liver; Mitochondria; Organic Anion Transporters; Organic Cation Transport Proteins; Rats; Uric Acid; Uricosuric Agents | 2018 |
Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Allopurinol; Benzbromarone; Case-Control Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Prevalence; Proportional Hazards Models; Taiwan; Treatment Outcome; Uric Acid; Young Adult | 2019 |
Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy.
Topics: Allopurinol; Animals; Benzbromarone; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; Hyperuricemia; Inflammation; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Retina; Risk Factors; Uric Acid; Vitreous Body; Xanthine Oxidase | 2019 |
Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients.
Topics: Adult; Allopurinol; Benzbromarone; Biomarkers; Cholesterol; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hypercholesterolemia; Hypertriglyceridemia; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Triglycerides; Uric Acid; Uricosuric Agents | 2019 |
Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.
Topics: Aged; Alcohol Drinking; Allopurinol; Benzbromarone; Diet Therapy; Febuxostat; Female; Foot Joints; Fructose; Gout; Gout Suppressants; Humans; Male; Meat; Middle Aged; Prospective Studies; Purines; Shellfish; Tomography, X-Ray Computed; Uric Acid; Uricosuric Agents | 2020 |
Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.
Topics: Allopurinol; Benzbromarone; Disease Progression; Febuxostat; Female; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Recovery of Function; Renal Insufficiency, Chronic; Treatment Outcome; Uric Acid; Uricosuric Agents | 2019 |
Clinical efficacy and safety of benzbromarone in elderly hypertensive patients with hyperuricemia.
Topics: Aged; Benzbromarone; Blood Pressure; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension; Hyperuricemia; Incidence; Male; Treatment Outcome; Uric Acid; Uricosuric Agents | 2019 |
Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.
Topics: Animals; Benzbromarone; Disease Models, Animal; Febuxostat; HEK293 Cells; Humans; Hyperuricemia; Kidney; Male; Mice, Inbred ICR; Organic Anion Transporters; Organic Cation Transport Proteins; Uric Acid | 2019 |
Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation.
Topics: Adult; AMP-Activated Protein Kinases; Animals; Atherosclerosis; Benzbromarone; Biomarkers; Disease Models, Animal; Enzyme Inhibitors; Female; HEK293 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammasomes; Inflammation; Inflammation Mediators; Interleukin-18; Interleukin-1beta; Leukocytes, Mononuclear; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Nuclear Factor 45 Protein; Plaque, Atherosclerotic; Reactive Oxygen Species; Receptors, LDL; Urate Oxidase; Uric Acid; Uricosuric Agents; Xanthine Oxidase; Young Adult | 2020 |
Characterizations of the Urate Transporter, GLUT9, and Its Potent Inhibitors by Patch-Clamp Technique.
Topics: Animals; Benzbromarone; Biological Transport; Gene Expression; Glucose Transport Proteins, Facilitative; Gout Suppressants; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Mice; Naphthalenes; Patch-Clamp Techniques; Plasmids; Potassium; Probenecid; Propionates; Pyridines; Transgenes; Uric Acid | 2021 |
Repair of Bone Erosion With Effective Urate-Lowering Therapy in a Patient With Tophaceous Gout.
Topics: Benzbromarone; Bone Resorption; Enzyme Inhibitors; Gout; Humans; Male; Metatarsal Bones; Metatarsophalangeal Joint; Middle Aged; Nitriles; Osteogenesis; Osteophyte; Pyridines; Treatment Outcome; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2021 |
Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications.
Topics: Actins; Animals; Apoptosis; Atrial Fibrillation; Atrial Remodeling; bcl-2-Associated X Protein; Benzbromarone; Biomarkers; Caspase 3; Cells, Cultured; Disease Models, Animal; Fibrosis; Heart Atria; Hyperuricemia; Male; Myocytes, Cardiac; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Uric Acid; Uricosuric Agents | 2021 |
Novel monocyclic amide-linked phenol derivatives without mitochondrial toxicity have potent uric acid-lowering activity.
Topics: Amides; Animals; Benzbromarone; Drug Evaluation, Preclinical; Glucose Transport Proteins, Facilitative; Humans; Mitochondria; Phenol; Pyrroles; Sapajus apella; Signal Transduction; Structure-Activity Relationship; Uric Acid; Uricosuric Agents | 2021 |
Drastic monosodium urate crystal dissolution with febuxostat and benzbromarone.
Topics: Allopurinol; Benzbromarone; Febuxostat; Gout; Gout Suppressants; Humans; Solubility; Uric Acid | 2021 |
Synthesis and bioactivity evaluation of novel nuciferine derivatives with antihyperuricemia and nephroprotective effects.
Topics: Animals; Aporphines; Benzbromarone; Hyperuricemia; Mice; Molecular Docking Simulation; Organic Anion Transporters; Phosphatidylinositol 3-Kinases; Uric Acid | 2022 |
Hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester in hyperuricemic mice through inhibiting XOD and down-regulating URAT1.
Topics: Allopurinol; Animals; Benzbromarone; Esters; Hydroxybenzoates; Hyperuricemia; Kidney; Mice; Uric Acid; Xanthine Oxidase | 2022 |
Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents.
Topics: Animals; Benzbromarone; Hyperuricemia; Mice; Organic Anion Transporters; Organic Cation Transport Proteins; Uric Acid; Uricosuric Agents | 2022 |
Short-Term Hyperuricemia Leads to Structural Retinal Changes That Can be Reversed by Serum Uric Acid Lowering Agents in Mice.
Topics: Allopurinol; Angiotensin II; Animals; Benzbromarone; Hyperuricemia; Macular Degeneration; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred ICR; Uric Acid | 2022 |
Cardiovascular risk of urate-lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Topics: Allopurinol; Benzbromarone; Cardiovascular Diseases; Febuxostat; Gout; Gout Suppressants; Heart Disease Risk Factors; Humans; Insurance, Health; Japan; Risk Factors; Treatment Outcome; Uric Acid | 2023 |
Uricosuric Agents Affect Plasma and Kidney Concentration of Adefovir via Inhibition of Oat1 and Mrp2 in Rats.
Topics: Animals; Benzbromarone; Kidney; Organic Anion Transporters; Probenecid; Rats; Rats, Sprague-Dawley; Uric Acid; Uricosuric Agents | 2023 |
The risk of ischemic cerebrovascular disease associated with benzbromarone use in gout people: A retrospective cohort study in Taiwan.
Topics: Benzbromarone; Cerebrovascular Disorders; Gout; Gout Suppressants; Humans; Retrospective Studies; Taiwan; Uric Acid; Uricosuric Agents | 2023 |
Superiority of low-dose benzbromarone to low-dose febuxostat in gout patients with renal uric acid underexcretion: comment on the article by Yan et al.
Topics: Allopurinol; Benzbromarone; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Treatment Outcome; Uric Acid | 2023 |
Comparison of benzbromarone and allopurinol on the risk of chronic kidney disease in people with asymptomatic hyperuricemia.
Topics: Allopurinol; Benzbromarone; Female; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Uric Acid | 2023 |